NFKB1 and glioblastoma: TAMs expressing the scavenger receptor MARCO have been identified as pro-tumorigenic in IDH1-wildtype GBM, where they suppress TNF-α signaling via NF-κB and impair antigen presentation, limiting antitumor immune responses [46].